Ardelyx (ARDX) Tops Q4 EPS by 6c

Ardelyx (NASDAQ: ARDX) reported Q4 EPS of $0.06, $0.06 better than the analyst estimate of $0.00. Revenue for the quarter came in at $44.18 million versus the consensus estimate of $23.16 million.

For earnings history and earnings-related data on Ardelyx (ARDX) click here.

You May Also Be Interested In

• SpaceX shares gain as lock-up fears ease
• Korro Bio (KRRO) Tops Q2 EPS by 24c
• Barinthus Biotherapeutics plc (BRNS) Tops Q2 EPS by 2c